Geron (GERN) Financials

$1.25 -0.07 (-5.30%)

Closing price 04:00 PM Eastern

Extended Trading

$1.28 +0.03 (+2.80%)

As of 07:08 PM Eastern

Annual Income Statements for Geron

This table shows Geron's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Income / (Loss) Attributable to Common Shareholders	-36	0.05	-30	-28	-27	-69	-76	-116	-142	-184	-175
Consolidated Net Income / (Loss)	-36	0.05	-30	-28	-27	-69	-76	-116	-142	-184	-175
Net Income / (Loss) Continuing Operations	-36	0.05	-30	-28	-27	-69	-76	-116	-142	-184	-175
Total Pre-Tax Income	-36	0.05	-30	-28	-27	-69	-76	-116	-142	-184	-175
Total Operating Income	-36	-0.56	-31	-29	-31	-73	-77	-114	-139	-194	-174
Total Gross Profit	1.15	36	6.16	1.07	1.07	0.46	0.25	1.39	0.00	0.00	76
Total Revenue	1.15	36	6.16	1.07	1.07	0.46	0.25	1.39	0.00	0.00	77
Operating Revenue	1.15	36	6.16	1.07	1.07	0.46	0.25	1.39	0.00	0.00	77
Total Cost of Revenue	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	1.26
Operating Cost of Revenue	-	-	-	-	-	-	-	-	0.00	0.00	1.26
Total Operating Expenses	37	37	37	30	32	73	77	115	139	194	249
Selling, General & Admin Expense	17	18	19	19	19	21	26	30	44	69	146
Research & Development Expense	21	18	18	11	13	52	51	86	96	125	104
Total Other Income / (Expense), net	0.64	0.61	1.11	1.34	4.06	3.96	1.30	-2.11	-3.35	9.82	-0.84
Interest Expense	-	-	-	-	0.00	0.00	0.76	3.74	6.88	8.31	20
Interest & Investment Income	0.37	0.68	1.19	1.42	3.25	4.22	1.83	0.53	2.53	18	20
Other Income / (Expense), net	0.27	-0.07	-0.08	-0.08	0.81	-0.26	0.23	1.10	1.00	-0.02	-0.24
Basic Earnings per Share	($0.23)	$0.00	($0.19)	($0.18)	($0.15)	($0.36)	($0.28)	($0.35)	($0.37)	($0.32)	($0.27)
Weighted Average Basic Shares Outstanding	153.54M	158.04M	159.05M	159.22M	176.50M	190.16M	271.46M	327.63M	380.78M	570.65M	646.03M
Diluted Earnings per Share	($0.23)	$0.00	($0.19)	($0.18)	($0.15)	($0.36)	($0.28)	($0.35)	($0.37)	($0.32)	($0.27)
Weighted Average Diluted Shares Outstanding	153.54M	162.66M	159.05M	159.22M	176.50M	190.16M	271.46M	327.63M	380.78M	570.65M	646.03M
Weighted Average Basic & Diluted Shares Outstanding	155.10M	158.92M	159.05M	159.22M	176.50M	190.16M	271.46M	327.63M	508.72M	546.06M	636.90M

This table shows Geron's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Income / (Loss) Attributable to Common Shareholders	-41	-43	-38	-49	-45	-52	-55	-67	-26	-25
Consolidated Net Income / (Loss)	-41	-43	-38	-49	-45	-52	-55	-67	-26	-25
Net Income / (Loss) Continuing Operations	-41	-43	-38	-49	-45	-52	-55	-67	-26	-25
Total Pre-Tax Income	-41	-43	-38	-49	-45	-52	-55	-67	-26	-25
Total Operating Income	-40	-42	-40	-52	-48	-54	-56	-69	-28	-20
Total Gross Profit	0.30	-0.42	0.00	0.03	0.16	-0.19	0.00	0.87	28	47
Total Revenue	0.30	-0.42	0.00	0.03	0.16	-0.19	0.00	0.88	28	48
Total Cost of Revenue	0.00	-	0.00	0.00	0.00	-	0.00	0.02	0.46	0.78
Total Operating Expenses	40	42	40	52	48	54	56	70	56	67
Selling, General & Admin Expense	16	14	13	16	18	21	27	39	36	43
Research & Development Expense	25	28	27	35	29	33	29	31	20	23
Total Other Income / (Expense), net	-1.10	-0.68	1.97	2.72	2.81	2.32	0.74	1.95	1.77	-5.30
Interest Expense	1.82	2.01	1.92	2.00	2.07	2.32	3.43	3.32	3.05	10
Interest & Investment Income	0.85	1.24	3.85	4.74	4.97	4.60	4.24	5.33	4.88	5.16
Other Income / (Expense), net	-0.14	0.09	0.04	-0.01	-0.09	0.04	-0.06	-0.06	-0.06	-0.05
Basic Earnings per Share	($0.10)	($0.11)	($0.07)	($0.09)	($0.08)	($0.08)	($0.09)	($0.10)	($0.04)	($0.04)
Weighted Average Basic Shares Outstanding	405.24M	380.78M	544.46M	547.28M	579.51M	570.65M	603.49M	653.90M	662.16M	646.03M
Diluted Earnings per Share	($0.10)	($0.11)	($0.07)	($0.09)	($0.08)	($0.08)	($0.09)	($0.10)	($0.04)	($0.04)
Weighted Average Diluted Shares Outstanding	405.24M	380.78M	544.46M	547.28M	579.51M	570.65M	603.49M	653.90M	662.16M	646.03M
Weighted Average Basic & Diluted Shares Outstanding	381.24M	508.72M	508.77M	523.37M	543.06M	546.06M	593.13M	602.80M	604.50M	636.90M

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Net Change in Cash & Equivalents	30	-22	-8.44	3.53	-5.76	3.07	-3.63	25	22	14	9.74
Net Cash From Operating Activities	9.35	-24	-18	-21	-21	-44	-67	-96	-127	-168	-219
Net Cash From Continuing Operating Activities	9.35	-24	-18	-21	-21	-44	-67	-96	-127	-168	-219
Net Income / (Loss) Continuing Operations	-36	0.05	-30	-28	-27	-69	-76	-116	-142	-184	-175
Consolidated Net Income / (Loss)	-36	0.05	-30	-28	-27	-69	-76	-116	-142	-184	-175
Depreciation Expense	0.05	0.06	0.08	0.08	0.06	0.06	0.16	0.22	0.29	0.44	0.55
Amortization Expense	2.89	2.10	0.55	0.27	-0.98	-0.82	1.77	2.89	0.94	-9.47	-12
Non-Cash Adjustments To Reconcile Net Income	7.63	11	10	6.76	7.55	18	6.73	5.90	6.88	21	35
Changes in Operating Assets and Liabilities, net	34	-37	0.32	0.26	-0.63	7.10	0.30	12	6.41	4.57	-67
Net Cash From Investing Activities	-78	0.07	8.76	23	-78	27	-105	72	62	-180	-106
Net Cash From Continuing Investing Activities	-78	0.07	8.76	23	-78	27	-105	72	62	-180	-106
Purchase of Property, Plant & Equipment	-0.13	-0.09	-0.06	-	-0.02	-0.41	-0.40	-0.21	-0.43	-0.83	-0.68
Purchase of Investments	-190	-206	-129	-100	-188	-153	-313	-177	-258	-476	-477
Sale and/or Maturity of Investments	112	207	138	123	111	181	208	248	321	296	372
Net Cash From Financing Activities	98	2.58	1.17	1.11	93	19	168	49	87	362	334
Net Cash From Continuing Financing Activities	98	2.58	1.17	1.11	93	19	168	49	87	362	334
Repayment of Debt	-	-	-	-	-	-	-	-	0.00	0.00	-87
Issuance of Debt	-	-	-	-	0.00	0.00	24	25	0.00	30	121
Issuance of Common Equity	98	2.58	1.17	1.11	93	19	144	21	72	226	173
Other Financing Activities, net	-	-	-	-	0.00	0.00	0.02	2.48	15	106	126

This table details how cash moves in and out of Geron's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Net Change in Cash & Equivalents	-15	-4.26	56	-56	-26	40	120	-73	-56	19
Net Cash From Operating Activities	-30	-35	-46	-30	-51	-41	-62	-53	-59	-44
Net Cash From Continuing Operating Activities	-30	-35	-46	-30	-51	-41	-62	-53	-59	-44
Net Income / (Loss) Continuing Operations	-41	-43	-38	-49	-45	-52	-55	-67	-26	-25
Consolidated Net Income / (Loss)	-41	-43	-38	-49	-45	-52	-55	-67	-26	-25
Depreciation Expense	0.08	0.08	0.10	0.12	0.11	0.11	0.11	0.26	0.03	0.14
Amortization Expense	0.23	-0.58	-1.33	-2.84	-2.96	-2.34	-1.40	-1.67	-1.82	-7.23
Non-Cash Adjustments To Reconcile Net Income	2.18	0.93	3.07	4.04	7.64	6.08	4.97	13	6.91	10
Changes in Operating Assets and Liabilities, net	8.98	7.03	-10	18	-11	7.18	-11	2.67	-38	-22
Net Cash From Investing Activities	9.84	19	-179	-44	-4.71	48	34	-36	-0.55	-104
Net Cash From Continuing Investing Activities	9.84	19	-179	-44	-4.71	48	34	-36	-0.55	-104
Purchase of Property, Plant & Equipment	-0.17	-0.14	-0.37	-0.20	-0.19	-0.06	-0.62	-0.21	-	0.14
Purchase of Investments	-40	-161	-242	-114	-104	-16	-66	-161	-66	-185
Sale and/or Maturity of Investments	50	180	63	70	99	64	100	125	65	81
Net Cash From Financing Activities	4.78	12	281	18	29	33	148	17	3.58	166
Net Cash From Continuing Financing Activities	4.78	12	281	18	29	33	148	17	3.58	166
Issuance of Common Equity	1.20	0.22	221	0.57	1.04	3.58	148	16	3.57	5.62
Other Financing Activities, net	3.64	12	60	18	28	-	0.05	0.37	0.00	126

This table presents Geron's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Total Assets	173	149	130	110	185	166	271	226	191	394	594
Total Current Assets	153	116	116	96	166	142	200	187	180	341	491
Cash & Equivalents	43	21	13	16	11	14	9.93	35	57	70	79
Restricted Cash	0.27	0.27	0.27	0.27	0.27	0.27	0.36	0.36	0.36	1.12	1.86
Short-Term Investments	109	93	102	78	153	126	186	149	116	264	328
Note & Lease Receivable	0.96	1.21	0.48	0.44	1.17	0.80	0.72	1.76	3.14	1.66	2.85
Accounts Receivable	-	-	-	-	-	-	-	-	-	0.00	36
Inventories, net	-	-	-	-	-	-	-	-	-	0.00	39
Prepaid Expenses	0.74	0.65	0.52	0.58	1.33	1.21	2.50	1.36	3.99	4.88	5.05
Plant, Property, & Equipment, net	0.17	0.21	0.18	0.10	0.06	0.41	0.66	0.65	0.79	1.18	1.31
Total Noncurrent Assets	19	33	14	14	19	24	70	38	9.54	52	101
Long-Term Investments	19	33	14	14	19	20	63	29	0.00	43	95
Other Noncurrent Operating Assets	-	-	-	-	0.59	3.85	6.83	9.53	9.54	8.25	6.96
Total Liabilities & Shareholders' Equity	173	149	130	110	185	166	271	226	191	394	594
Total Liabilities	42	6.63	7.87	6.52	7.55	30	60	100	111	146	313
Total Current Liabilities	42	6.63	7.87	6.52	7.55	28	31	46	77	108	88
Short-Term Debt	-	-	-	-	-	-	-	0.00	21	47	0.00
Accounts Payable	1.03	0.16	0.23	0.50	0.98	1.18	6.92	6.69	10	6.16	8.60
Accrued Expenses	1.54	3.45	4.80	0.93	1.32	7.53	15	30	33	40	36
Current Employee Benefit Liabilities	4.21	3.03	2.84	3.39	2.64	4.83	8.22	8.10	12	14	23
Other Current Liabilities	0.02	-	-	1.70	2.61	15	0.88	0.90	0.93	0.95	21
Total Noncurrent Liabilities	0.00	0.00	0.00	0.00	0.00	2.20	29	54	34	38	225
Long-Term Debt	-	-	-	-	-	0.00	24	50	30	35	118
Other Noncurrent Operating Liabilities	-	-	-	-	-	2.20	4.80	4.27	3.67	3.01	107
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	131	142	122	104	178	135	211	126	80	248	280
Total Preferred & Common Equity	131	142	122	104	178	135	211	126	80	248	280
Preferred Stock	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Common Equity	131	142	122	104	178	135	211	126	80	248	280
Common Stock	1,059	1,071	1,080	1,090	1,189	1,215	1,366	1,398	1,494	1,846	2,052
Retained Earnings	-928	-928	-958	-986	-1,011	-1,080	-1,156	-1,272	-1,414	-1,598	-1,772
Accumulated Other Comprehensive Income / (Loss)	-0.08	-0.21	-0.05	-0.21	-0.18	0.13	0.08	-0.17	-0.22	0.19	0.26

This table presents Geron's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric	Q3 2022	Q1 2023	Q2 2023	Q3 2023	Q1 2024	Q2 2024	Q3 2024
Total Assets	233	425	415	413	482	449	445
Total Current Assets	222	387	377	335	452	373	398
Cash & Equivalents	61	113	57	31	190	117	60
Restricted Cash	0.36	0.37	0.54	0.54	1.12	1.12	1.85
Short-Term Investments	134	268	314	283	253	246	279
Note & Lease Receivable	22	1.60	1.19	15	1.63	2.25	2.08
Accounts Receivable	-	-	-	-	-	0.87	28
Inventories, net	-	-	-	-	-	0.77	20
Prepaid Expenses	4.70	4.32	4.18	6.27	5.71	5.55	6.06
Plant, Property, & Equipment, net	0.73	1.07	1.15	1.23	1.68	1.63	1.60
Total Noncurrent Assets	9.80	37	37	77	29	74	45
Long-Term Investments	0.00	28	28	68	21	67	37
Other Noncurrent Operating Assets	9.80	8.69	8.59	8.88	8.10	7.96	7.99
Total Liabilities & Shareholders' Equity	233	425	415	413	482	449	445
Total Liabilities	124	99	117	122	137	143	153
Total Current Liabilities	83	44	73	89	123	104	138
Short-Term Debt	13	0.00	11	22	72	47	72
Accounts Payable	8.18	3.38	7.67	14	9.99	5.62	14
Accrued Expenses	53	35	45	42	34	39	36
Current Employee Benefit Liabilities	7.64	4.91	8.23	11	6.79	11	15
Other Current Liabilities	0.92	0.93	0.79	0.94	0.96	0.96	0.97
Total Noncurrent Liabilities	42	55	44	33	14	39	15
Long-Term Debt	38	51	41	30	11	37	12
Other Noncurrent Operating Liabilities	3.83	3.51	3.50	3.18	2.83	2.65	2.46
Commitments & Contingencies	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Total Equity & Noncontrolling Interests	108	326	298	291	345	307	292
Total Preferred & Common Equity	108	326	298	291	345	307	292
Total Common Equity	108	326	298	291	345	307	292
Common Stock	1,480	1,778	1,800	1,837	1,998	2,028	2,038
Retained Earnings	-1,371	-1,452	-1,501	-1,546	-1,653	-1,721	-1,747
Accumulated Other Comprehensive Income / (Loss)	-0.62	-0.16	-0.95	-0.95	-0.27	-0.54	1.02

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-	-
Revenue Growth	-10.13%	3,054.47%	-83.06%	-82.72%	0.09%	-56.85%	-45.00%	450.59%	-100.00%	0.00%	0.00%
EBITDA Growth	11.07%	104.60%	-2,076.10%	3.70%	-7.60%	-135.76%	-1.67%	-46.88%	-24.15%	-48.91%	8.60%
EBIT Growth	8.36%	98.25%	-4,769.89%	4.55%	-3.19%	-140.42%	-5.38%	-47.22%	-21.83%	-41.02%	10.31%
NOPAT Growth	6.79%	97.80%	-3,737.60%	4.54%	-6.21%	-133.34%	-6.08%	-48.22%	-21.54%	-39.98%	10.42%
Net Income Growth	7.06%	100.13%	-64,310.87%	5.49%	3.22%	-153.72%	-10.31%	-53.55%	-22.21%	-29.76%	5.19%
EPS Growth	23.33%	100.00%	0.00%	5.26%	16.67%	-140.00%	22.22%	-25.00%	-5.71%	13.51%	15.63%
Operating Cash Flow Growth	125.49%	-358.78%	24.08%	-11.91%	-2.20%	-108.62%	-52.07%	-43.37%	-33.30%	-31.69%	-30.33%
Free Cash Flow Firm Growth	126.03%	-535.48%	46.15%	-12.56%	-4.48%	-36.62%	-70.24%	-29.21%	-33.91%	-41.49%	49.28%
Invested Capital Growth	-537.61%	88.54%	-46.20%	19.28%	18.36%	-446.65%	-3.92%	-45.75%	-14.97%	-14.93%	-115.99%
Revenue Q/Q Growth	-3.92%	0.12%	-2.00%	10.02%	20.86%	-30.72%	-32.35%	373.81%	-100.00%	100.00%	165.86%
EBITDA Q/Q Growth	1.72%	19.64%	-1.76%	3.38%	-3.65%	-40.57%	9.14%	-7.53%	-9.79%	-7.47%	13.63%
EBIT Q/Q Growth	0.96%	37.77%	-0.45%	3.29%	-1.94%	-42.35%	8.06%	-7.30%	-8.59%	-6.82%	16.41%
NOPAT Q/Q Growth	0.72%	13.76%	-0.45%	3.29%	-6.16%	-39.20%	8.06%	-7.26%	-8.60%	-6.79%	16.46%
Net Income Q/Q Growth	0.93%	110.62%	-0.05%	3.63%	0.48%	-46.54%	6.53%	-7.63%	-8.09%	-5.34%	13.23%
EPS Q/Q Growth	11.54%	0.00%	-5.56%	5.26%	6.25%	-44.00%	20.00%	-2.94%	-5.71%	8.57%	12.90%
Operating Cash Flow Q/Q Growth	136.06%	-353.84%	20.20%	-22.57%	6.15%	-20.17%	-3.49%	-11.11%	-11.38%	-3.55%	-1.39%
Free Cash Flow Firm Q/Q Growth	132.41%	-1,639.75%	20.51%	-23.50%	3.81%	-0.67%	-9.25%	-10.57%	-10.65%	-4.46%	63.94%
Invested Capital Q/Q Growth	-654.91%	-18.10%	-643.83%	-21.33%	-240.05%	-249.50%	-46.95%	-23.18%	-15.83%	-22.47%	-3,594.54%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	0.00%	0.00%	98.37%
EBITDA Margin	-2,871.38%	4.19%	-488.41%	-2,721.41%	-2,925.61%	-15,984.13%	-29,546.64%	-7,882.20%	0.00%	0.00%	-240.98%
Operating Margin	-3,149.35%	-1.54%	-497.34%	-2,746.95%	-2,914.92%	-15,761.96%	-30,400.40%	-8,183.70%	0.00%	0.00%	-225.64%
EBIT Margin	-3,126.02%	-1.73%	-498.69%	-2,754.18%	-2,839.40%	-15,819.35%	-30,310.28%	-8,104.74%	0.00%	0.00%	-225.95%
Profit (Net Income) Margin	-3,093.67%	0.13%	-479.34%	-2,621.22%	-2,534.43%	-14,901.74%	-29,888.14%	-8,335.39%	0.00%	0.00%	-226.73%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	98.97%	-7.29%	96.12%	95.17%	89.26%	94.20%	98.61%	102.85%	103.16%	94.93%	100.35%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-37.45%	0.03%	-22.33%	-24.69%	-19.19%	-43.82%	-43.70%	-68.84%	-137.49%	-112.29%	-66.09%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-30.05%	-0.39%	-22.03%	-24.39%	-20.48%	-41.49%	-35.16%	-45.45%	0.00%	0.00%	-35.22%
Return on Assets (ROA)	-29.74%	0.03%	-21.17%	-23.21%	-18.28%	-39.08%	-34.67%	-46.75%	0.00%	0.00%	-35.34%
Return on Common Equity (ROCE)	-37.45%	0.03%	-22.33%	-24.69%	-19.19%	-43.82%	-43.70%	-68.84%	-137.49%	-112.29%	-66.09%
Return on Equity Simple (ROE_SIMPLE)	-27.29%	0.03%	-24.14%	-26.89%	-15.20%	-50.72%	-35.85%	-91.85%	-177.38%	-74.26%	-62.28%
Net Operating Profit after Tax (NOPAT)	-25	-0.56	-21	-20	-22	-51	-54	-80	-97	-136	-122
NOPAT Margin	-2,204.54%	-1.54%	-348.14%	-1,922.86%	-2,040.44%	-11,033.37%	-21,280.28%	-5,728.59%	0.00%	0.00%	-157.95%
Net Nonoperating Expense Percent (NNEP)	-8.66%	0.38%	-5.86%	-6.24%	-3.62%	-10.42%	-11.02%	-18.21%	-31.54%	-23.14%	-15.56%
Return On Investment Capital (ROIC_SIMPLE)	-19.45%	-0.39%	-17.53%	-19.73%	-12.24%	-37.55%	-22.91%	-45.28%	-73.95%	-41.15%	-30.49%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.63%
SG&A Expenses to Revenue	1,453.43%	48.92%	304.46%	1,810.99%	1,754.88%	4,541.96%	10,149.41%	2,129.58%	0.00%	0.00%	189.28%
R&D to Revenue	1,795.92%	49.03%	292.88%	1,035.96%	1,260.04%	11,320.00%	20,350.99%	6,154.13%	0.00%	0.00%	134.74%
Operating Expenses to Revenue	3,249.35%	101.54%	597.34%	2,846.95%	3,014.92%	15,861.96%	30,500.40%	8,283.70%	0.00%	0.00%	324.01%
Earnings before Interest and Taxes (EBIT)	-36	-0.63	-31	-29	-30	-73	-77	-113	-138	-194	-174
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-33	1.52	-30	-29	-31	-74	-75	-110	-136	-203	-186
Valuation Ratios	-	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	3.91	5.39	2.69	2.76	1.05	2.01	2.34	3.11	11.53	4.62	7.63
Price to Tangible Book Value (P/TBV)	3.91	5.39	2.69	2.76	1.05	2.01	2.34	3.11	11.53	4.62	7.63
Price to Revenue (P/Rev)	443.14	21.06	53.46	269.12	174.81	590.65	1,951.19	281.97	0.00	0.00	27.79
Price to Earnings (P/E)	0.00	16,647.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.01%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	295.14	17.02	32.52	166.59	3.95	244.46	1,018.45	165.02	0.00	0.00	22.80
Enterprise Value to EBITDA (EV/EBITDA)	0.00	406.50	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	36.40	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	41.27	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.11	0.39	0.64	0.33	0.42
Long-Term Debt to Equity	0.00	0.00	0.00	0.00	0.00	0.00	0.11	0.39	0.38	0.14	0.42
Financial Leverage	-1.24	-1.16	-1.04	-1.05	-1.03	-1.09	-1.14	-1.18	-1.38	-1.28	-1.29
Leverage Ratio	1.26	1.18	1.05	1.06	1.05	1.12	1.26	1.47	2.02	1.78	1.87
Compound Leverage Factor	1.25	-0.09	1.01	1.01	0.94	1.06	1.24	1.51	2.08	1.69	1.88
Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.23%	28.27%	39.01%	24.84%	29.71%
Short-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	15.97%	14.21%	0.00%
Long-Term Debt to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	10.23%	28.27%	23.04%	10.63%	29.71%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	89.77%	71.73%	61.00%	75.16%	70.29%
Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.32	-0.45	-0.38	-0.40	-0.64
Net Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	3.16	1.48	0.89	1.46	2.07
Long-Term Debt to EBITDA	0.00	0.00	0.00	0.00	0.00	0.00	-0.32	-0.45	-0.22	-0.17	-0.64
Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.45	-0.62	-0.53	-0.60	-0.97
Net Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	4.38	2.04	1.26	2.18	3.16
Long-Term Debt to NOPAT	0.00	0.00	0.00	0.00	0.00	0.00	-0.45	-0.62	-0.31	-0.26	-0.97
Altman Z-Score	-0.11	61.64	15.09	13.99	7.66	-4.39	-1.21	-6.40	-7.11	-1.89	-0.11
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-	-
Current Ratio	3.67	17.47	14.76	14.73	21.99	5.03	6.46	4.11	2.35	3.16	5.56
Quick Ratio	3.65	17.33	14.66	14.60	21.78	4.98	6.37	4.07	2.29	3.10	5.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	8.25	-36	-19	-22	-23	-31	-53	-68	-92	-129	-66
Operating Cash Flow to CapEx	7,137.40%	-26,884.44%	-44,802.44%	0.00%	-131,306.25%	-10,612.35%	-107,503.23%	0.00%	-29,554.29%	-20,210.00%	-32,149.71%
Free Cash Flow to Firm to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-69.60	-18.27	-13.30	-15.58	-3.25
Operating Cash Flow to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-87.70	-25.55	-18.51	-20.18	-10.82
Operating Cash Flow Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-87.78	-25.18	-18.57	-20.28	-10.85
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.01	0.23	0.04	0.01	0.01	0.00	0.00	0.01	0.00	0.00	0.16
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	8.70	191.43	31.60	7.47	13.24	1.97	0.47	2.13	0.00	0.00	61.92
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.17
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	2,144.08
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-2,144.08
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-	-
Invested Capital	-40	-4.57	-6.69	-5.40	-4.41	-24	-25	-36	-42	-48	-104
Invested Capital Turnover	-0.05	-1.63	-1.09	-0.18	-0.22	-0.03	-0.01	-0.05	0.00	0.00	-1.01
Increase / (Decrease) in Invested Capital	-34	35	-2.11	1.29	0.99	-20	-0.95	-11	-5.46	-6.26	-56
Enterprise Value (EV)	340	619	200	177	4.21	112	258	230	801	850	1,755
Market Capitalization	511	766	329	287	186	272	494	393	923	1,146	2,140
Book Value per Share	$0.83	$0.90	$0.77	$0.65	$0.95	$0.68	$0.68	$0.39	$0.21	$0.46	$0.46
Tangible Book Value per Share	$0.83	$0.90	$0.77	$0.65	$0.95	$0.68	$0.68	$0.39	$0.21	$0.46	$0.46
Total Capital	131	142	122	104	178	135	235	176	131	330	399
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00	24	50	51	82	118
Total Long-Term Debt	0.00	0.00	0.00	0.00	0.00	0.00	24	50	30	35	118
Net Debt	-171	-147	-129	-109	-182	-159	-236	-163	-122	-296	-384
Capital Expenditures (CapEx)	0.13	0.09	0.04	0.00	0.02	0.41	0.06	-1.39	0.43	0.83	0.68
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-40	-4.78	-6.87	-5.50	-5.05	-26	-28	-42	-49	-55	-5.73
Debt-free Net Working Capital (DFNWC)	112	109	108	89	159	113	169	142	124	280	403
Net Working Capital (NWC)	112	109	108	89	159	113	169	142	104	233	403
Net Nonoperating Expense (NNE)	10	-0.61	8.08	7.44	5.27	18	22	36	45	48	53
Net Nonoperating Obligations (NNO)	-171	-147	-129	-109	-182	-159	-236	-163	-122	-296	-384
Total Depreciation and Amortization (D&A)	2.94	2.15	0.63	0.35	-0.92	-0.76	1.93	3.10	1.23	-9.03	-12
Debt-free, Cash-free Net Working Capital to Revenue	-3,477.88%	-13.15%	-111.49%	-516.43%	-473.83%	-5,684.57%	-10,956.92%	-3,043.86%	0.00%	0.00%	-7.44%
Debt-free Net Working Capital to Revenue	9,679.71%	300.40%	1,756.62%	8,399.44%	14,869.32%	24,662.17%	66,765.61%	10,171.21%	0.00%	0.00%	523.02%
Net Working Capital to Revenue	9,679.71%	300.40%	1,756.62%	8,399.44%	14,869.32%	24,662.17%	66,765.61%	10,171.21%	0.00%	0.00%	523.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.23)	$0.00	($0.19)	($0.18)	($0.15)	($0.36)	($0.28)	($0.35)	($0.37)	($0.32)	($0.27)
Adjusted Weighted Average Basic Shares Outstanding	157.70M	158.04M	159.05M	159.22M	186.39M	200.34M	318.53M	323.73M	380.78M	570.65M	646.03M
Adjusted Diluted Earnings per Share	($0.23)	$0.00	($0.19)	($0.18)	($0.15)	($0.36)	($0.28)	($0.35)	($0.37)	($0.32)	($0.27)
Adjusted Weighted Average Diluted Shares Outstanding	157.70M	162.66M	159.05M	159.22M	186.39M	200.34M	318.53M	323.73M	380.78M	570.65M	646.03M
Adjusted Basic & Diluted Earnings per Share	($0.23)	$0.00	$0.00	$0.00	($0.15)	($0.36)	($0.28)	($0.35)	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	153.54M	158.92M	159.16M	160.65M	176.50M	190.16M	271.46M	327.63M	508.72M	546.06M	636.90M
Normalized Net Operating Profit after Tax (NOPAT)	-25	0.52	-21	-20	-22	-51	-54	-80	-97	-136	-122
Normalized NOPAT Margin	-2,204.54%	1.44%	-348.14%	-1,922.86%	-2,040.44%	-11,033.37%	-21,280.28%	-5,728.59%	0.00%	0.00%	-157.95%
Pre Tax Income Margin	-3,093.67%	0.13%	-479.34%	-2,621.22%	-2,534.43%	-14,901.74%	-29,888.14%	-8,335.39%	0.00%	0.00%	-226.73%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-100.90	-30.19	-19.99	-23.34	-8.61
NOPAT to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-70.84	-21.34	-14.09	-16.33	-6.02
EBIT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-100.98	-29.82	-20.05	-23.44	-8.64
NOPAT Less CapEx to Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	-70.92	-20.97	-14.16	-16.43	-6.05
Payout Ratios	-	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

This table displays calculated financial ratios and metrics derived from Geron's official financial filings.

Metric	Q3 2022	Q4 2022	Q1 2023	Q2 2023	Q3 2023	Q4 2023	Q1 2024	Q2 2024	Q3 2024	Q4 2024
Growth Metrics	-	-	-	-	-	-	-	-	-	-
Revenue Growth	0.00%	-136.55%	-100.00%	0.00%	-44.78%	54.05%	0.00%	2,941.38%	17,138.41%	24,888.08%
EBITDA Growth	-59.43%	-40.25%	-47.52%	-108.80%	-27.10%	-33.30%	-39.24%	-29.49%	40.53%	51.86%
EBIT Growth	-55.67%	-35.10%	-39.41%	-93.41%	-19.00%	-29.58%	-40.30%	-33.55%	40.72%	62.95%
NOPAT Growth	-55.60%	-35.40%	-39.82%	-85.70%	-19.18%	-29.41%	-40.01%	-33.46%	40.74%	63.07%
Net Income Growth	-53.77%	-33.16%	-26.66%	-75.08%	-9.14%	-21.90%	-45.30%	-36.88%	40.97%	51.22%
EPS Growth	-25.00%	-22.22%	22.22%	-28.57%	20.00%	27.27%	-28.57%	-11.11%	50.00%	50.00%
Operating Cash Flow Growth	-29.52%	-58.70%	-36.47%	-3.35%	-71.86%	-16.36%	-34.27%	-80.66%	-15.94%	-7.35%
Free Cash Flow Firm Growth	-296.70%	-133.59%	-194.06%	35.76%	-41.24%	-32.79%	-26.60%	-335.14%	-86.58%	232.00%
Invested Capital Growth	-22.27%	-14.97%	-4.75%	-84.38%	-8.70%	-14.93%	-17.59%	19.74%	92.84%	-115.99%
Revenue Q/Q Growth	0.00%	-241.41%	100.00%	0.00%	465.52%	-217.68%	100.00%	0.00%	3,105.33%	69.22%
EBITDA Q/Q Growth	-51.89%	-6.52%	2.55%	-32.43%	7.54%	-11.71%	-1.79%	-23.17%	57.54%	9.57%
EBIT Q/Q Growth	-49.21%	-4.44%	4.33%	-29.73%	8.19%	-13.72%	-3.59%	-23.49%	59.25%	28.93%
NOPAT Q/Q Growth	-42.79%	-5.01%	4.43%	-29.58%	8.35%	-14.02%	-3.40%	-23.51%	59.31%	28.94%
Net Income Q/Q Growth	-46.00%	-3.86%	10.59%	-29.13%	8.98%	-16.00%	-6.57%	-21.65%	60.75%	4.14%
EPS Q/Q Growth	-42.86%	-10.00%	36.36%	-28.57%	11.11%	0.00%	-12.50%	-11.11%	60.00%	0.00%
Operating Cash Flow Q/Q Growth	-3.28%	-18.93%	-31.79%	36.16%	-71.75%	19.48%	-52.07%	14.10%	-10.22%	25.44%
Free Cash Flow Firm Q/Q Growth	-2.22%	-11.87%	-11.40%	49.57%	-124.76%	-5.17%	-6.21%	-73.32%	3.63%	174.41%
Invested Capital Q/Q Growth	-33.24%	-15.83%	24.32%	-57.86%	21.45%	-22.47%	22.57%	-7.75%	92.99%	-3,594.54%
Profitability Metrics	-	-	-	-	-	-	-	-	-	-
Gross Margin	100.00%	0.00%	0.00%	100.00%	100.00%	0.00%	0.00%	98.07%	98.39%	98.36%
EBITDA Margin	-13,392.26%	0.00%	0.00%	-188,544.83%	-30,826.22%	0.00%	0.00%	-8,027.55%	-106.34%	-56.83%
Operating Margin	-13,450.51%	0.00%	0.00%	-179,141.38%	-29,031.71%	0.00%	0.00%	-7,860.88%	-99.80%	-41.91%
EBIT Margin	-13,496.97%	0.00%	0.00%	-179,179.31%	-29,087.80%	0.00%	0.00%	-7,868.03%	-100.02%	-42.01%
Profit (Net Income) Margin	-13,821.89%	0.00%	0.00%	-169,748.28%	-27,320.12%	0.00%	0.00%	-7,639.80%	-93.55%	-52.99%
Tax Burden Percent	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Interest Burden Percent	102.41%	101.84%	95.18%	94.74%	93.92%	95.81%	98.57%	97.10%	93.53%	126.14%
Effective Tax Rate	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Invested Capital (ROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
ROIC Less NNEP Spread (ROIC-NNEP)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Net Nonoperating Assets (RNNOA)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Return on Equity (ROE)	-101.09%	-137.49%	-70.80%	-77.66%	-87.66%	-112.29%	-60.04%	-72.56%	-69.03%	-66.09%
Cash Return on Invested Capital (CROIC)	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Operating Return on Assets (OROA)	-91.73%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-15.52%	-6.75%	-6.55%
Return on Assets (ROA)	-93.94%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-15.07%	-6.32%	-8.26%
Return on Common Equity (ROCE)	-101.09%	-137.49%	-70.80%	-77.66%	-87.66%	-112.29%	-60.04%	-72.56%	-69.03%	-66.09%
Return on Equity Simple (ROE_SIMPLE)	-121.37%	0.00%	-45.98%	-57.31%	-60.14%	0.00%	-58.40%	-71.59%	-68.83%	0.00%
Net Operating Profit after Tax (NOPAT)	-28	-29	-28	-36	-33	-38	-39	-49	-20	-14
NOPAT Margin	-9,415.35%	0.00%	0.00%	-125,398.97%	-20,322.20%	0.00%	0.00%	-5,502.62%	-69.86%	-29.34%
Net Nonoperating Expense Percent (NNEP)	-8.04%	-9.32%	-4.14%	-4.97%	-4.84%	-6.68%	-4.35%	-5.42%	-2.14%	-3.33%
Return On Investment Capital (ROIC_SIMPLE)	-17.59%	-22.39%	-7.44%	-10.39%	-9.73%	-11.52%	-9.19%	-12.44%	-5.25%	-3.52%
Cost of Revenue to Revenue	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	1.93%	1.61%	1.64%
SG&A Expenses to Revenue	5,266.67%	0.00%	0.00%	56,862.07%	11,189.02%	0.00%	0.00%	4,469.27%	126.90%	90.66%
R&D to Revenue	8,283.84%	0.00%	0.00%	122,379.31%	17,942.68%	0.00%	0.00%	3,489.68%	71.29%	48.98%
Operating Expenses to Revenue	13,550.51%	0.00%	0.00%	179,241.38%	29,131.71%	0.00%	0.00%	7,958.96%	198.19%	139.64%
Earnings before Interest and Taxes (EBIT)	-40	-42	-40	-52	-48	-54	-56	-69	-28	-20
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)	-40	-42	-41	-55	-51	-56	-57	-71	-30	-27
Valuation Ratios	-	-	-	-	-	-	-	-	-	-
Price to Book Value (P/BV)	8.17	11.53	3.39	5.47	3.82	4.62	5.23	8.20	9.36	7.63
Price to Tangible Book Value (P/TBV)	8.17	11.53	3.39	5.47	3.82	4.62	5.23	8.20	9.36	7.63
Price to Revenue (P/Rev)	563.48	0.00	0.00	0.00	0.00	0.00	0.00	2,948.28	94.50	27.79
Price to Earnings (P/E)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dividend Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Earnings Yield	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Enterprise Value to Invested Capital (EV/IC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Revenue (EV/Rev)	471.45	0.00	0.00	0.00	0.00	0.00	0.00	2,541.57	84.31	22.80
Enterprise Value to EBITDA (EV/EBITDA)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to EBIT (EV/EBIT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to NOPAT (EV/NOPAT)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Operating Cash Flow (EV/OCF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Enterprise Value to Free Cash Flow (EV/FCFF)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Leverage & Solvency	-	-	-	-	-	-	-	-	-	-
Debt to Equity	0.47	0.64	0.16	0.17	0.18	0.33	0.24	0.27	0.29	0.42
Long-Term Debt to Equity	0.35	0.38	0.16	0.14	0.10	0.14	0.03	0.12	0.04	0.42
Financial Leverage	-1.25	-1.38	-1.15	-1.18	-1.19	-1.28	-1.10	-1.15	-1.07	-1.29
Leverage Ratio	1.78	2.02	1.47	1.48	1.62	1.78	1.35	1.43	1.47	1.87
Compound Leverage Factor	1.82	2.06	1.40	1.41	1.52	1.71	1.33	1.39	1.38	2.36
Debt to Total Capital	31.94%	39.01%	13.62%	14.75%	15.15%	24.84%	19.35%	21.39%	22.29%	29.71%
Short-Term Debt to Total Capital	8.15%	15.97%	0.00%	3.10%	6.44%	14.21%	16.73%	12.03%	19.03%	0.00%
Long-Term Debt to Total Capital	23.78%	23.04%	13.62%	11.66%	8.71%	10.63%	2.62%	9.36%	3.26%	29.71%
Preferred Equity to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Noncontrolling Interests to Total Capital	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Common Equity to Total Capital	68.06%	61.00%	86.38%	85.25%	84.85%	75.16%	80.65%	78.61%	77.71%	70.29%
Debt to EBITDA	-0.41	-0.38	-0.34	-0.29	-0.27	-0.40	-0.38	-0.35	-0.39	-0.64
Net Debt to EBITDA	1.16	0.89	2.39	1.96	1.75	1.46	1.74	1.47	1.37	2.07
Long-Term Debt to EBITDA	-0.30	-0.22	-0.34	-0.23	-0.16	-0.17	-0.05	-0.16	-0.06	-0.64
Debt to NOPAT	-0.57	-0.53	-0.49	-0.42	-0.41	-0.60	-0.56	-0.52	-0.58	-0.97
Net Debt to NOPAT	1.62	1.26	3.41	2.86	2.60	2.18	2.60	2.18	2.03	3.16
Long-Term Debt to NOPAT	-0.42	-0.31	-0.49	-0.34	-0.23	-0.26	-0.08	-0.23	-0.08	-0.97
Altman Z-Score	-3.83	-5.45	2.58	3.79	0.53	-0.72	3.51	5.43	5.82	0.75
Noncontrolling Interest Sharing Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Liquidity Ratios	-	-	-	-	-	-	-	-	-	-
Current Ratio	2.68	2.35	8.81	5.20	3.75	3.16	3.67	3.61	2.89	5.56
Quick Ratio	2.62	2.29	8.71	5.13	3.67	3.10	3.61	3.53	2.68	5.04
Cash Flow Metrics	-	-	-	-	-	-	-	-	-	-
Free Cash Flow to Firm (FCFF)	-21	-24	-27	-13	-30	-32	-34	-58	-56	42
Operating Cash Flow to CapEx	-17,299.42%	-25,129.29%	-12,463.71%	-14,653.96%	-26,478.65%	-63,965.63%	-10,122.44%	-25,960.19%	0.00%	0.00%
Free Cash Flow to Firm to Interest Expense	-11.76	-11.92	-13.85	-6.70	-14.61	-13.67	-9.82	-17.60	-18.48	4.02
Operating Cash Flow to Interest Expense	-16.28	-17.55	-24.12	-14.78	-24.61	-17.64	-18.13	-16.11	-19.35	-4.22
Operating Cash Flow Less CapEx to Interest Expense	-16.37	-17.62	-24.32	-14.88	-24.70	-17.67	-18.31	-16.17	-19.35	-4.21
Efficiency Ratios	-	-	-	-	-	-	-	-	-	-
Asset Turnover	0.01	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.07	0.16
Accounts Receivable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fixed Asset Turnover	2.34	0.00	0.00	0.00	0.00	0.00	0.00	0.62	20.50	61.92
Accounts Payable Turnover	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.03	0.17
Days Sales Outstanding (DSO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Inventory Outstanding (DIO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Days Payable Outstanding (DPO)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	142,704.26	10,578.83	2,144.08
Cash Conversion Cycle (CCC)	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-142,704.26	-10,578.83	-2,144.08
Capital & Investment Metrics	-	-	-	-	-	-	-	-	-	-
Invested Capital	-36	-42	-32	-50	-39	-48	-37	-40	-2.82	-104
Invested Capital Turnover	-0.05	0.00	0.00	0.00	0.00	0.00	0.00	-0.02	-1.37	-1.01
Increase / (Decrease) in Invested Capital	-6.60	-5.46	-1.44	-23	-3.15	-6.26	-5.59	9.89	37	-56
Enterprise Value (EV)	740	801	746	1,285	780	850	1,420	2,168	2,442	1,755
Market Capitalization	884	923	1,104	1,633	1,110	1,146	1,802	2,515	2,737	2,140
Book Value per Share	$0.29	$0.21	$0.64	$0.59	$0.56	$0.46	$0.63	$0.52	$0.48	$0.46
Tangible Book Value per Share	$0.29	$0.21	$0.64	$0.59	$0.56	$0.46	$0.63	$0.52	$0.48	$0.46
Total Capital	159	131	377	350	343	330	428	390	376	399
Total Debt	51	51	51	52	52	82	83	83	84	118
Total Long-Term Debt	38	30	51	41	30	35	11	37	12	118
Net Debt	-144	-122	-358	-349	-330	-296	-382	-347	-295	-384
Capital Expenditures (CapEx)	0.17	0.14	0.37	0.20	0.19	0.06	0.62	0.21	0.00	-0.14
Debt-free, Cash-free Net Working Capital (DFCFNWC)	-43	-49	-38	-56	-46	-55	-44	-47	-9.94	-5.73
Debt-free Net Working Capital (DFNWC)	152	124	343	316	268	280	400	317	332	403
Net Working Capital (NWC)	139	104	343	305	246	233	328	270	260	403
Net Nonoperating Expense (NNE)	13	13	10	13	11	14	16	19	6.70	11
Net Nonoperating Obligations (NNO)	-144	-122	-358	-349	-330	-296	-382	-347	-295	-384
Total Depreciation and Amortization (D&A)	0.31	-0.50	-1.23	-2.72	-2.85	-2.23	-1.29	-1.41	-1.79	-7.09
Debt-free, Cash-free Net Working Capital to Revenue	-2,736.20%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-5,530.13%	-34.33%	-7.44%
Debt-free Net Working Capital to Revenue	9,701.72%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	37,126.03%	1,145.32%	523.02%
Net Working Capital to Revenue	8,875.78%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	31,625.79%	898.22%	523.02%
Earnings Adjustments	-	-	-	-	-	-	-	-	-	-
Adjusted Basic Earnings per Share	($0.10)	($0.11)	($0.07)	($0.09)	($0.08)	($0.08)	($0.09)	($0.10)	($0.04)	($0.04)
Adjusted Weighted Average Basic Shares Outstanding	405.24M	380.78M	544.46M	547.28M	579.51M	570.65M	603.49M	653.90M	662.16M	646.03M
Adjusted Diluted Earnings per Share	($0.10)	($0.11)	($0.07)	($0.09)	($0.08)	($0.08)	($0.09)	($0.10)	($0.04)	($0.04)
Adjusted Weighted Average Diluted Shares Outstanding	405.24M	380.78M	544.46M	547.28M	579.51M	570.65M	603.49M	653.90M	662.16M	646.03M
Adjusted Basic & Diluted Earnings per Share	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00	$0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding	381.24M	508.72M	508.77M	523.37M	543.06M	546.06M	593.13M	602.80M	604.50M	636.90M
Normalized Net Operating Profit after Tax (NOPAT)	-28	-29	-28	-36	-33	-38	-39	-49	-20	-14
Normalized NOPAT Margin	-9,415.35%	0.00%	0.00%	-125,398.97%	-20,322.20%	0.00%	0.00%	-5,502.62%	-69.86%	-29.34%
Pre Tax Income Margin	-13,821.89%	0.00%	0.00%	-169,748.28%	-27,320.12%	0.00%	0.00%	-7,639.80%	-93.55%	-52.99%
Debt Service Ratios	-	-	-	-	-	-	-	-	-	-
EBIT to Interest Expense	-22.06	-20.88	-20.84	-25.94	-23.09	-23.37	-16.37	-20.91	-9.28	-1.93
NOPAT to Interest Expense	-15.39	-14.65	-14.60	-18.16	-16.13	-16.37	-11.45	-14.62	-6.48	-1.35
EBIT Less CapEx to Interest Expense	-22.16	-20.95	-21.03	-26.04	-23.18	-23.40	-16.55	-20.97	-9.28	-1.92
NOPAT Less CapEx to Interest Expense	-15.48	-14.72	-14.80	-18.26	-16.22	-16.40	-11.63	-14.68	-6.48	-1.33
Payout Ratios	-	-	-	-	-	-	-	-	-	-
Dividend Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
Augmented Payout Ratio	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%

Frequently Asked Questions About Geron's Financials

When does Geron's fiscal year end?

According to the most recent income statement we have on file, Geron's financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Geron's net income changed over the last 10 years?

Geron's net income appears to be on an upward trend, with a most recent value of -$174.57 million in 2024, rising from -$35.67 million in 2014. The previous period was -$184.13 million in 2023.

What is Geron's operating income?

Geron's total operating income in 2024 was -$173.73 million, based on the following breakdown:

Total Gross Profit: $75.74 million
Total Operating Expenses: $249.47 million

How has Geron revenue changed over the last 10 years?

Over the last 10 years, Geron's total revenue changed from $1.15 million in 2014 to $76.99 million in 2024, a change of 6,577.7%.

How much debt does Geron have?

Geron's total liabilities were at $313.46 million at the end of 2024, a 114.5% increase from 2023, and a 649.9% increase since 2014.

How much cash does Geron have?

In the past 10 years, Geron's cash and equivalents has ranged from $9.93 million in 2020 to $79.02 million in 2024, and is currently $79.02 million as of their latest financial filing in 2024.

How has Geron's book value per share changed over the last 10 years?

Over the last 10 years, Geron's book value per share changed from 0.83 in 2014 to 0.46 in 2024, a change of -44.2%.

Remove Ads

Related Companies

This page (NASDAQ:GERN) was last updated on 4/15/2025 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Geron (GERN) Financials

Frequently Asked Questions About Geron's Financials

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Geron (GERN) Financials

Annual Income Statements for Geron

Quarterly Income Statements for Geron

Annual Cash Flow Statements for Geron

Quarterly Cash Flow Statements for Geron

Annual Balance Sheets for Geron

Quarterly Balance Sheets for Geron

Annual Metrics and Ratios for Geron

Quarterly Metrics and Ratios for Geron

Frequently Asked Questions About Geron's Financials

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools